MEASURABLE RESIDUAL DISEASE MONITORING FOR ACUTE MYELOID LEUKEMIA (AML MRD) (OS533)
Method
FLOWCYTOMETRY
Turnaround Time
SAMPLE DAILY BY 8:00 PM, REPORT AFTER 7-10 DAYS
Sample Type
3 ML (1 ML MIN.) FIRST PULL ASPIRATE OF BONE MARROW IN 1 GREEN TOP (SODIUM HEPARIN) TUBE. MIX THOROUGHLY. MANDATORY REQUIREMENTS AT THE TIME OF REGISTRATION ARE: SAMPLE TIME POINT (CHEMOTHERAPY TIME POINTS); PREVIOUS DIAGNOSTIC IMMUNOPHENOTYPE REPORT; CLINICAL HISTORY & ORIGINAL TRF; DATE & TIME WHEN SAMPLE WAS DRAWN TO BE MENTIONED ON THE TRF; 1 OR 2 UNSTAINED BONE MARROW ASPIRATE SMEARS MADE AT SOURCE.
How to Prepare
MANDATORY REQUIREMENTS AT THE TIME OF REGISTRATION ARE: SAMPLE TIME POINT (CHEMOTHERAPY TIME POINTS); PREVIOUS DIAGNOSTIC IMMUNOPHENOTYPE REPORT; CLINICAL HISTORY & ORIGINAL TRF; DATE & TIME WHEN SAMPLE WAS DRAWN TO BE MENTIONED ON THE TRF; 1 OR 2 UNSTAINED BONE MARROW ASPIRATE SMEARS MADE AT SOURCE.
More Tests
View AllPRADER-WILLI SYNDROME MUTATION DETECTION METHYLATION SPECIFIC PCR
Turn Around Time
REPORT AFTER 15 DAYS
REPORT AFTER 15 DAYS
Rs. 16000
B-CELL CD20 EXPRESSION BY FLOWCYTOMETRY
Turn Around Time
SAMPLE DAILY BY 4:00 PM REPORT AFTER 3 DAY LATE EVENING
SAMPLE DAILY BY 4:00 PM REPORT AFTER 3 DAY LATE EVENING
Rs. 5000